|
Description
The ECM 830 is a Square Wave Electroporation System designed for all in vitro and in vivo electroporation
applications. The generator utilizes the new BTX Power Platform Technology and an all-new digital user
interface.
All BTX T 820 square wave electroporation protocols are easily reproducible
with the ECM 830 electroporation system. The ECM 830 possesses key features
including finer voltage discrimination, Arc Quenching, the monitoring of all
key parameters, and the control of pulse intervals.
Mammalian Cell Transfections/Gene Therapy
The use of square wave pulses for the transfection of mammalian cells is well
established. Fakhrai has used the BTX T 820 in the technique of Electro-Immuno
Therapy.1 The ECM 830 will enable transfection of mammalian cells while
maintaining higher cell viability.2 For many mammalian cells, higher
transfection efficiencies will also be obtained.3
Mammalian Cell Protein/Drug Electroincorporation
Square wave pulses have been used to electroincorporate a variety of molecules
into mammalian cells; Tsong has used square wave to load drugs into erythrocytes4
while Marrero has used the BTX T 820 and BTX Model 366 Petri Dish Electrode to
incorporate biologically active antibodies into RASM cells.5
In Vivo Applications
Recent advances by Genetronics and BTX have allowed researchers to perform in vivo
electroporation. In vivo Electro Gene Therapy has significant advantages over viral
mediated gene transfer, biolistics, and the use of cationic lipids.6,7,8
Nuclear Transfer
BTX square wave systems have been used by the experts in mammalian embryo
manipulation techniques in nuclear transfer for applications ranging from
pharmaceutical production to organ generation. 9,10,11
Plant Applications
Intact plant tissue and protoplasts may be transformed using electroporation12,
and references indicate that square wave is indeed superior to exponential
decay for plant protoplast transformation.13
Bacterial and Yeast Electroporation
The ECM 830 is capable of reproducing our T 820 bacterial protocols,
including all four E coli electrotransformation protocols referencing
transformation efficiencies equivalent or superior to exponential decay results.14
| Standard Capabilities |
| |
Interface: |
|
Digital User Interface |
|
Input: |
|
110 V/220 V Universal |
|
Charge Time: |
|
13 sec maximum |
|
Voltage Range: |
|
5 - 500 V LV Mode/ 1 V resolution
505 - 3000 V HV Mode/ 5 V resolution
|
|
Pulse Length Range: |
|
10 ms - 999 ms LV Mode/ 1 ms resolution
1 µsec - 999µsec LV Mode/ 1 µsec resolution
1 sec - 10 sec LV Mode/ 0.1 sec resolution
10 µs - 600 µs HV Mode/ 1 µs resolution
|
|
Multiple Pulsing: |
|
1 - 99 pulses |
|
Pulse Interval: |
|
100 msec - 10 sec |
|
Programmability: |
|
Storage for 3 setups (V, t, n, interval) |
|
Arc Control: |
|
Arc Quenching |
| |
| Other Electrical Characteristics |
|
Capacitance: |
|
4000 µF LV, 110 µF HV |
|
Amperage: |
|
500 A LV, 100 A HV |
| |
| Physical Characteristics |
|
Footprint: |
|
12.5" x 12.25" x 5.5" (W-D-H) |
|
Weight: |
|
15 lbs. (6.8 kg) |
|
Display: |
|
20 x 4 character LCD |
|
Controls: |
|
Single Rotary Encoder with push button toggle between all set parameters.
Additional on/off Power and Start switches |
| |
| Monitoring: |
|
Displays all set parameters after pulsing |
| Remote Operation: |
|
Footswitch available. Please contact BTX Technical Services at
1-800-272-2775 or techsupport.btx@harvardapparatus.com for assistance.
|
System
| Model |
|
Available Configurations |
| 8300 |
|
ECM 830 Electroporation System
ECM 830 Generator with Power Supply
Model 630 B Safety Stand
Model 610, 620, 640 Disposable
Electroporation Cuvettes Plus 10 ea.
Model 660 Cuvette Rack
Manuals and Instruction Sheets
|
| Model |
|
Description |
| 610 |
|
Cuvettes Plus, 1 mm gap, 50/pkg
|
| 620 |
|
Cuvettes Plus, 2 mm gap, 50/pkg
|
| 640 |
|
Cuvettes Plus, 4 mm gap, 50/pkg
|
- Fakhrai, H. et al., PNAS, 93: 2909- 2914 (1996)
- Pasco, David, University of Mississippi, Natural Products Center, Personal Communication and Protocols PR0296-0298, PR0345-349, PR0351-355 (1998)
- Takahashi, M. et al., Leukemia Research, 15 (6): 507-513 (1991)
- Tsong, T., et al., Biblthca Haemat, 51: 108-114 (1985)
- Marrero, M., et al., The Journal of Biological Chemistry, 270 (26): 15734-15738 (1995)
- Miramatsu et al., International Journal of Molecular Medicine, 1: 55-62 (1998)
- Nishi, T., et al., Cancer Research, 56: 1050-1055 (1996)
- Heller, R., et al., FEBS Letters, 389: 225-228 (1996)
- Cambell, K., PPL Therapeutics, Roslin, Scotland, Personal Communication (1998)
- Cibelli, Jose et al., Science, 280: 1256-1258 (1998)
- Meng, J., et al., Biology of Reproduction, 57: 454-459 (1997)
- Lin, C., et al., Plant Physiol. Biochem., 35 (12): 959-968 (1997)
- Saunders, J., Guide to Electroporation and Electrofusion, 227-247 (1991)
- BTX Protocols PR0182, PR0183, PR0336, PR0342 (1998)
- Costaglioli, P., et al., Current Genetics, 27 (1): 26-30 (1994)
This product meets the requirements of the European Communities (EC),
and complies with EMC Directive 89/336/EEC and 73/23/EEC for product safety.
|